MedTrace Logo

RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.

NCT06755658 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-01-01

No results posted yet for this study

Summary

This is a retrospective, non-interventional nor experimental study conducted at the General Hospital of Athens "Sismanoglio - A. Fleming / A. Fleming Hospital Unit" in hospitalized covid-19 patients who will be tested for RDW, PLT and MPV / PLT ratio, parameters in routine complete blood counts, in relation to mortality risk, during the years 2020-2021, since November 2020, when the hospital was designated, by Ministerial decision, exclusively for the treatment of covid-19 patients until June 2021, a period corresponding to the prevalence of the delta subtype, according to the local epidemiological surveillance of the National Public Health Organization of Greece. (https://eody.gov.gr/).

Conditions

  • Infection by SARS-COV-2

Sponsors & Collaborators

  • Sismanoglio General Hospital

    lead OTHER

Principal Investigators

  • Despoina Georgiadou, MD · Sismanogleio Hospital, Sismanogliou 1, Marousi 151 26, Athens, Greece. Amalia Fleming Clinical Unit/ Hematology Department, 25 Martiou, 14, Melissia, 15127, Athens,Greece.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2025-02-01
Completion
2025-05-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06755658 on ClinicalTrials.gov